PPARG and urinary bladder neoplasm: These recurrent PPARγ mutations (p = 0.015) and PPARG amplifications (p = 1.5 × 10–5) were significantly enriched in bladder tumors presenting a PPARγ activation signature, which were mostly luminal tumors (p = 2.2 × 10–16), as shown by Fisher’s exact test.